PharPoint Research Expands Collaboration with Medrio amid Recent Growth

PharPoint Research Expands Collaboration with Medrio amid Recent Growth

SAN FRANCISCO, CA–(Marketwired – December 14, 2016) – PharPoint Research, a North Carolina-based Contract Research Organization (CRO), has committed to a contractual expansion in the number of clinical trials they will conduct with Medrio, a Software as a Service (SaaS) company providing electronic data capture (EDC) services to clinical trials. This agreement is a direct result of the growth of PharPoint Research, as evidenced by their recent Fast 50 award by the Triangle Business Journal.

The commitment between the two companies strengthens their partnership and reflects the value that PharPoint Research has placed in Medrio’s services during this period of rapid growth. PharPoint Research views Medrio as one of the top EDCs for quick study build and high data quality, and therefore as conducive to the efficiency that PharPoint Research will require as it continues to emerge as an industry leader and one of the busiest CROs in the region. “With our growth, we continue to utilize Medrio as our primary tool for data capture,” said Moya Hawkins, Director of Data Management at PharPoint Research. “Medrio helps us to facilitate a streamlined and rapid approach to study start-up while maintaining clean data throughout a study’s lifecycle.”

PharPoint Research and Medrio have enjoyed a mutually productive relationship for many years, beginning in 2010 when PharPoint put their first project in Medrio’s EDC system. In 2013, PharPoint Research joined Medrio’s Partner Program, through which Medrio provides extensive sales and marketing support, offers previews of upcoming product developments, facilitates new business opportunities for participating CROs, and more. PharPoint Research has found the Partner Program to be a valuable resource throughout the journey toward its current growth, and continues to take advantage of the program’s benefits.

Of the increased use of Medrio by PharPoint Research in the coming year, Mike Novotny, founder and CEO of Medrio, said, “Nothing could be more rewarding than knowing that PharPoint Research has found the capabilities of our software, and the benefits of our partner program, to be so helpful during their explosive growth. We’re honored that they’ve chosen to expand their business with us over the next year.”

About PharPoint Research

PharPoint Research is a full-service contract research organization (CRO) that specializes in Project Management, Clinical Monitoring, Data Management and Biostatistics. The company is uniquely poised to serve the needs of pharmaceutical, biotechnology, and medical device development organizations. PharPoint Research is experienced in strategic consulting engagements and Phase 1 through Phase 4 clinical research projects across a variety of therapeutic areas, including infectious disease, oncology, CNS, cardiovascular, and rare disease indications. PharPoint Research is headquartered in North Carolina, with strategic operations service provider partners around the world, including North and South America, Europe, and Asia-Pacific. For more information, please visit

About the Fast 50 Award

The Triangle Business Journal, a weekly business newspaper, is the leading provider of local business news for the Raleigh-Durham–Chapel Hill area of North Carolina. Each year the Triangle Business Journal honors the fastest growing companies in the Research Triangle area of North Carolina with the Fast 50 Awards. PharPoint Research received the award in recognition of the significant growth that the company has experienced over the last 12 months. This growth is the direct result of providing excellent client service, expertise and uncompromised quality to the pharmaceutical and biotechnology industry. This is the fourth time since 2011 that PharPoint Research has won this annual award.

About Medrio

Medrio offers an integrated eClinical software platform with a fully hosted EDC system. Our technology features an easy-to-use drag-and-drop interface, allowing study managers to build their studies in days instead of months without requiring any programming. Medrio’s new mobile suite, mSource, supports both event-based and subject-based workflows, offline data entry, and Patient Reported Outcomes (PRO). Although Medrio has extensive experience in all study phases, our m1 application leads the way in early-phase and Phase 1 trials, with over 500 Phase 1 trials to date. Medrio costs up to 75% less than traditional EDC solutions. For more information, please visit our website. To schedule a demo and learn more about Medrio’s Partner Program, please submit your information here and a member of our team will be in touch shortly.


PharPoint Research
Tim LaCroix

Michelle Wilcox

About the Author

Leave a Reply